Document Actions
Hans Mak Institute
Business focus: The Hans Mak Institute aims to improve quality of care of renal patients by supporting clinical and biomedical research in kidney disease.
 |
Hans Mak Institute Employees in Amsterdam: 15 |
Company profile
The Hans Mak Institute (HMi) is an independent institute for quality management in the field of kidney diseases. It was founded in 2003 by the Dutch Kidney Foundation, the Dutch Renal Patient Association and the Dutch Federation of Nephrology. The scope of the HMi is to boost improvements in the quality of care throughout the ‘renal chain’, including patients with kidney diseases, chronic renal failure, pre-dialysis, dialysis and transplantation. Its goal is a coherent quality system embedding initiatives related to quality of care. The HMi supports and promotes these activities and starts new developments. To this purpose an important tool is the large experience of the HMi in facilitating and supporting clinical multi-centre studies and trials in nephrology. The HMi hosts large databases and is involved in national, European and global studies on genetic factors influencing the outcome of kidney disease. Furthermore the HMi is involved in new developments in the field of self management including new technical tools for self monitoring of clinical outcome and diagnostic parameters.
Science and Technologies or Services
The HMi is an expert in the execution of clinical trials including data management, monitoring by clinical research assistants and data analysis. The institute collaborates with national and international research institutes and with innovative enterprises being involved in nanotechnology and the development of domotica.
Alliances
The Hans Mak Institute cooperates with the Dutch Renal Patient Association, the Dutch Kidney Foundation and Dutch nephrologists. The HMi collaborates with all University Medical Centres in the Netherlands and (inter)national research institutes like Karolinska Institute Stockholm, Montréal Nephrology Consortium, Cardiovascular Research Univerity of Manchester, Charite Berlin, UCL medical School Brussels, Mario Negri Institute Bergamo, University Hospital Aachen. The HMi is involved in P3G (Public Population Project in Genomics, Canada) and cooperates with Medimate, Enschede in the development of technical devices for self monitoring of clinical parameters in kidney disease.
Keywords
-
Kidney disease
-
Quality of care
-
Multi center studies
-
Genomics
-
Self management